Merit Medical Systems, Inc. vs Pfizer, Inc. — Stock Comparison
Merit Medical Systems, Inc. (MMSI) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merit Medical Systems, Inc. scores ahead of Pfizer, Inc. on Q·Score (7.7 vs 6.4 out of 10), led by Growth (8.1 vs 5.1) and Sentiment (8 vs 5.3). Pfizer, Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for MMSI (+33.2%) than for PFE (+15.8%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $89.55 is 33% above current price.
Forward P/E of 8.9× is low relative to sector peers.
⚠ earnings contracting 10% year-over-year.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MMSI vs PFE: which stock scores better overall?
Based on Q·Score, Merit Medical Systems, Inc. (MMSI) scores 7.7/10 versus Pfizer, Inc. (PFE) at 6.4/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MMSI or PFE?
Merit Medical Systems, Inc. (MMSI) scores higher on Growth (8.1/10 vs 5.1/10). Merit Medical Systems, Inc. reports revenue growth (7.5% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MMSI or PFE more attractively valued?
Merit Medical Systems, Inc. (MMSI) scores higher on Valuation (9.2/10 vs 7.7/10). MMSI trades at 15.3× P/E versus PFE at 8.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MMSI vs PFE?
There are 11 analysts covering MMSI with a consensus price target of $89.55, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MMSI or PFE?
Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 5.7/10). Net profit margin: MMSI at 9.0%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MMSI or PFE?
Merit Medical Systems, Inc. (MMSI) scores higher on Financial Health (8.2/10 vs 7/10). Market beta: MMSI at 0.53, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MMSI and PFE?
Merit Medical Systems, Inc. (MMSI) has a market capitalisation of $4.0B, while Pfizer, Inc. (PFE) has a market cap of $143.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MMSI or PFE pay dividends?
MMSI does not currently pay a dividend, while PFE pays a dividend yield of 6.82%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →